Antimicrobial Agents and Chemotherapy · 2017 · 83 citations · 9 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceMedical MicrobiologyMicrobial PathogenesisAcquired ResistanceAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance EvolutionAntibiotic Resistance MechanismsBeta-lactam ResistanceAmpc Beta-lactamase-mediated ResistanceAmpc Beta-lactamasesBeta-lactamase Inhibitor ResistanceCephalosporin ResistanceCephalosporin TherapyPseudomonas Aeruginosa ResistanceResistance In Clinical IsolatesStructural Mutation
ABSTRACT Ceftolozane-tazobactam is a cephalosporin-β-lactamase inhibitor combination that exhibits potent in vitro activity against Pseudomonas aeruginosa , including strains that are resistant to other β-lactams. The emergence of ceftolozane-tazobactam resistance among clinical isolates of P. aeruginosa has rarely been described. Here we characterized ceftolozane-tazobactam-resistant P. aeruginosa strains recovered from a patient who was treated with this agent for 6 weeks for a recurrent wound infection. The results showed that the resistance was mediated by a single AmpC structural mutation.
9
Multilocus Sequence Typing of Total-Genome-Sequenced Bacteria
Mette Voldby Larsen, Salvatore Cosentino, Simon Rasmussen et al. · Journal of Clinical Microbiology · 2012 · 2.4K citations · Full text
Ryan K. Shields, Liang Chen, Shaoji Cheng et al. · Antimicrobial Agents and Chemotherapy · 2016 · 485 citations · Full text
Ghady Haidar, Nathan J Philips, Ryan K. Shields et al. · Clinical Infectious Diseases · 2017 · 276 citations · Full text
Gabriel Cabot, Sebastian Bruchmann, Xavier Mulet et al. · Antimicrobial Agents and Chemotherapy · 2014 · 242 citations · Full text